An agonist of adenosine A2A receptor and inhibitor of ENT1
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
A2AR agonist-1 is an agonist of the adenosine A2A receptor and an inhibitor of equilibrative nucleoside transporter 1 (ENT1; Kis = 4.39 and 3.47 ?M for the human receptor and guinea pig transporter, respectively).1 It decreases adenosine uptake by 80% in PC12 cells when used at a concentration of 61 ?M and increases brain levels of adenosine in a transgenic mouse model of Huntington’s disease when administered at a dose of 20 mg/kg.2 A2AR agonist-1 (0.11 mg/kg) also rescues motor performance and increases survival in a transgenic mouse model of Huntington’s disease.
1.Chen, J.-B., Liu, E.M., Chern, T.-R., et al.Design and synthesis of novel dual-action compounds targeting the adenosine A(2A) receptor and adenosine transporter for neuroprotectionChem. Med. Chem.6(8)1390-1400(2011) 2.Kao, Y.H., Lin, M.S., Chen, C.M., et al.Targeting ENT1 and adenosine tone for the treatment of Huntington's diseaseHum. Mol. Genet.26(3)467-478(2017)
5'-(N-Cyclopropyl)carboxamidoadenosine
¥670.00 ¥837.00
没有评价数据